Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1130 | Thyroid cancer | ECE2018

Follicular thyroid carcinoma with late metastasis to kidney in a patient with elevated thyroglobulin levels of unknown source

Katkar Rujuta , Shah Manasi , Ryan John A , Odonnell Amy

Here we present a case of follicular thyroid cancer with elevation of thyroglobulin (Tg, in ng/ml) detected almost 10 years after initial surgery and radioactive iodine therapy (RAI). The elevated Tg persisted for years before he was found to have a metastasis in his kidney 16 years after his initial cancer treatment. A 78 year old male had a total thyroidectomy followed by RAI therapy in 2001 for a 2.4 cm follicular thyroid cancer. His Tg became mildly elevated in 2009, and c...

ea0002p63 | Neuroendocrinology | SFE2001

The effect of metabolites of MDMA ('ecstasy') on the release of vasopressin in vitro

Forsling M , Fallon J , Shah D , Kicman A , Hutt A , Cowan D

Vasopressin release is stimulated following the administration of 3,4-methylenedioxymethamphetamine (MDMA ) in man. MDMA and a major metabolite, 4-hydroxy-3-methoxymethamphetamine (HMMA), have also been shown to stimulate neurohypophysial hormone release in vitro. A study has now been performed comparing the response to four other metabolites with the parent compound. Hypothalami obtained from male Wistar rats were exposed to medium alone (B1) and the medium containing ...

ea0094p179 | Adrenal and Cardiovascular | SFEBES2023

Rare case of a giant Adrenal Schwannoma

Viswanath Aditya , Dales Jolyon , Levy Miles , Shah Vikas

Introduction: Adrenal schwannomas are rare but important causes of adrenal tumours which can often only be diagnosed histologically. We present an interesting case of an incidentally detected adrenal schwannoma.Case: A 67-year-old gentleman had an ultrasound imaging of the abdomen that incidentally revealed a large right adrenal mass prompting referral to the endocrinology service. His past medical history included myoca...

ea0094p186 | Bone and Calcium | SFEBES2023

Teriparatide efficacy in the real world: a single UK centre experience

Shah Preet , Crossland Helen , Abbas Afroze , Seejore Khyatisha

Introduction: Teriparatide is an osteoanabolic agent approved for the treatment of osteoporosis in postmenopausal women, in men with increased fracture risk, and in glucocorticoid-induced osteoporosis. The aim of this study was to evaluate the real-world use and efficacy of teriparatide.Patients and Methods: We retrospectively assessed all patients with available data, who received teriparatide at Leeds Teaching Hospital...

ea0095p27 | Diabetes 1 | BSPED2023

Type 1 diabetes associated with primary sclerosing cholangitis and inflammatory bowel disease – a rare autoimmune combination

Shah Shilpa , Millar Sarinda , Gupte Girish , McLaughlin Louise

Introduction: Type 1 diabetes is an autoimmune condition resulting in insulin deficiency. Surveillance of other autoimmune disorders such as coeliac disease and hypothyroidism is common practice due to their higher co association. We describe a case of a 14 year old girl with 2 rarer autoimmune conditions; primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD)Case summary: A 14 year old girl presented ...

ea0095p105 | Diabetes 3 | BSPED2023

Management of diabetic ketoacidosis in 0 to 16 years presenting to the Southern Health and Social Care Trust between January 2020 and September 2022

Shah Shilpa , McVeigh Shane , Murphy Rebekah , Abdin Asma , Millar Sarinda

Introduction: Diabetic Ketoacidosis is a life threatening emergency. BSPED has updated their guideline with changes in the fluid management (bolus dose for shock, de-escalate early use of inotropes, percentage dehydration in moderate DKA and maximum weight)Aims: To determine the clinical features and outcome of new presentations of DKA in 0–16 year age range and audit fluid managementM...

ea0096p11 | Section | UKINETS2023

How gallstones can affect the course of PRRT

Coldham Mr. Chris , Smith Mrs Stacey , Shah Dr. Tahir

Introduction/Background: Somatostatin analogue injections are a mainstay for the treatment of Neuroendocrine Tumours. Gallstones are a known adverse effect of this treatment. PRRT can bring extra complications for patients having an episode of cholecystitis, biliary colic, cholangitis or pancreatitis.Aims: To examine a cohort of patients undergoing PRRT, looking for the incidence of gallstones and how many patients suffe...

ea0070ep554 | Hot topics (including COVID-19) | ECE2020

Patient reported changes in metabolic health during COVID-19 induced lockdown – a cross sectional digital connect survey in type 2 diabetes

Kovil Rajiv , Shah Tejas , Chawla Manoj , Karkhanis Shefali , Padhye Dakshata , Sanghvi Ami , Kale Mayura , Chawla Purvi , Prabhu Nikhil , Dhandhania Vinay , Shah Kiran

Introduction: During the COVID-19 induced lockdown it is imperative that people with T2DM be aware, disciplined, and sensitive to achieve glycemic control to mitigate the risks of COVID 19.Methods: We conducted a cross sectional survey to map the overall short-term impact of nationwide lockdown on the metabolic parameters and change in healthful behaviour patterns among patients from pooled practices of 21 diabetologists across 343 patients, with 30 ques...

ea0076p5 | Abstracts | CHD2021

Nutritional recovery is essential for successful management of patients with advanced carcinoid heart disease

Shah Husnain , Mair Reena , Arif Sayqa , Smith Stacey , Vickrage Suzanne , Kemp-Blake Joanne , Denham Samuel , Oelofse Tessa , Singh Harjot , Singh Stephen , Steeds Richard , Shah Tahir

Introduction Chronic heart failure is a catabolic state leading to cachexia in 5-15% of patients, predicting poor survival outcomes. Malnutrition affects 40% of patients with NETs and 58% with carcinoid syndrome (CS). Case 45M with severe carcinoid heart disease, on referral and admission was cachectic with BMI of 16, having lost 32 kg or 30% of body weight, meeting 50% of dietary requirements and at risk of refeeding syndrome. Nasogastric feeding (NG) w...

ea0077cc2 | (1) | SFEBES2021

Familial hypocalciuric hypercalcaemia (FHH) type 3: A rare cause of parathyroid (PTH) dependent hypercalcaemia with associated learning disabilities and behavioural problems

Shah Najeeb , Amjad Masroor , Benamer Sufyan , Deshmukh Harshal , Sathyapalan Thozhukat , Mohammed Kamrudeen

Case: A 25-year-old male with a history of Asperger’s syndrome, not on regular medication, with no family history of endocrinopathy; was referred with mild hypercalcaemia found during routine investigations for fatigue, weight loss, diarrhoea and vomiting. A normal PTH suggested PTH-dependent hypercalcaemia. There was no history of fractures or nephrolithiasis. DEXA scan showed normal bone mineral density (femur, spine and forearm). The gastrointestinal symptoms and fatig...